XNAS · MRNA

-2.36% · -$1.49 · Vol 4.6M

Market closed · last close 4:00 PM ET · price as of 19:55:28 ET

Moderna, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

$61.66

Card

Relationship Map

Veridion Score

Refresh

Score snapshot refresh in progress

Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS

HISTORY WINDOW BUILDING

AI Analysis

Sovereign

Why is MRNA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move MRNA next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Jul 17
Score
Score moved -9
58/NEUTRAL -> 49/NEUTRAL
Veridion score historySource
Jul 6
CongressChecking access
Ro Khanna purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jun 9
CongressChecking access
Ro Khanna sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
May 11
CongressChecking access
Ro Khanna purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Feb 6
CongressChecking access
Ro Khanna purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Sep 9
CongressChecking access
Ro Khanna sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Aug 7
CongressChecking access
Ro Khanna purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jun 10
CongressChecking access
Ro Khanna sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access

Catalyst calendar

Dated receipts for MRNA are being assembled.

About Moderna, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Founded

2010

Listed

2018

Employees

Country

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$61.68

Day high

$63.28

Day low

$61.06

Previous close

$63.15

52W high

$81.80

-24.62% from high

52W low

$22.36

66% of range

Market cap

$24.5B

EPS

$-8.5600

Beta

1.52

Shares out

396.8M

Volume

4.6M

0.53× rel vol

Avg volume

8.6M

VWAP

$62.13

Price history computed in-house

-7.98%

-3.60%

+13.70%

+97.25%

YTD

+109.09%

SMA 50 $57.09 · above

SMA 200 $43.39 · above

52W position 66%

Veridion warehouse edge

Warehouse intelligence for MRNA.

Veridion Score

Checking plan access.

Congress 30d

Ro Khanna · Purchase

Insider activity

See Form 4 panel below.

13F holders

None on file

Capital Web snapshots checked.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.

Related public evidence

Relationship mapTrace receipt-backed holders and filings around MRNA.Congress disclosuresOpen receipt and filing context for MRNA.MethodologyReview score inputs, coverage rules, and limitations.

Data ledger

Quote and day range

Refresh interval: 30 seconds

Source: Market data

Veridion Score

Coverage building

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Statements refresh in progress

SEC Form 4 ledger

MRNA insider activity

Moderna, Inc. Common Stock

Score

Coverage building

Pressure

Mixed

Filings

Buys / sells

0 / 0

Net value

Not disclosed

Insiders

Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for MRNA.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

SEC Form 4 ledger

Receipt-backed filing rows for MRNA are being assembled from the latest scheduled snapshot.

Congress · 90D

Congress filing snapshot refresh in progress

Federal contracts

MRNA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for MRNA in this window.

Lobbying spend

MRNA lobbying filings, year to date.

Registered lobbying filings matched to Moderna, Inc. Common Stock.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for MRNA in this window.

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Composite trend over time

Why is MRNA moving today?

What can move MRNA next.

Warehouse intelligence for MRNA.

Continue the MRNA research trail.

MRNA insider activity

MRNA contract awards, year to date.

MRNA lobbying filings, year to date.

Cross-references from this score page.

What can move MRNA next.

MRNA insider activity

Cross-references from this score page.